In T1D patients, soluble OX40 and OX40L expression in the serum is significantly upregulated and considered as potential indicators for disease progression, while membrane OX40 and OX40L expression on immune cells is significantly downregulated compared with the healthy controls (164). The gene discussed is TNFSF4; the disease is type 1 diabetes mellitus.